Skip to content
MedsAcross

Manufacturer

Radha Pharmaceuticals

Products listed
26
Molecules
10
Therapy areas
7

Radha Pharmaceuticals is a pharmaceutical manufacturer based in an unrecorded country. MedsAcross lists 26 of its products across 10 molecules, each with registers, packs and availability for export supply to licensed buyers.

Indian manufacturer
No
Also listed as
Radha Pharmaceuticals, INC., Radha Pharmaceuticals INC, Radha Pharmaceuticals Inc, Radha Pharmaceuticals, Inc, Radha Pharmaceuticals, Inc.
US FDA labeler
YesSource: openFDA NDC directory

Source from this manufacturer

We supply Radha Pharmaceuticals products through licensed channels, with the documents your regulator needs.

Psychiatry

9 presentations

Psychiatry overview
MedicineActive ingredientRegisterAvailability
Bupropion 100 mg extended-release tabletOralGeneric nameBupropionUS FDAAvailable on request
Bupropion 200 mg extended-release tabletOralGeneric nameBupropionUS FDAAvailable on request
Bupropion Hydrochloride (XL) 150 mg extended-release tabletOralBupropionUS FDAAvailable on request
Bupropion Hydrochloride (XL) 300 mg extended-release tabletOralBupropionUS FDAAvailable on request
Buspirone 30 mg tabletOralGeneric nameBuspironeUS FDAAvailable on request
Buspirone 7.5 mg tabletOralGeneric nameBuspironeUS FDAAvailable on request
Fluoxetine 10 mg capsuleOralGeneric nameFluoxetineUS FDAAvailable on request
Fluoxetine 20 mg capsuleOralGeneric nameFluoxetineUS FDAAvailable on request
Fluoxetine 40 mg capsuleOralGeneric nameFluoxetineUS FDAAvailable on request

Cardiology

6 presentations

Cardiology overview
MedicineActive ingredientRegisterAvailability
Hydralazine 10 mg tabletOralGeneric nameHydralazineUS FDAAvailable on request
Hydralazine 100 mg tabletOralGeneric nameHydralazineUS FDAAvailable on request
Hydralazine 25 mg tabletOralGeneric nameHydralazineUS FDAAvailable on request
Hydralazine 50 mg tabletOralGeneric nameHydralazineUS FDAAvailable on request
Ranolazine 1000 mg extended-release tabletOralGeneric nameRanolazineUS FDAAvailable on request
Ranolazine 500 mg extended-release tabletOralGeneric nameRanolazineUS FDAAvailable on request

Antifungals

4 presentations

Antifungals overview
MedicineActive ingredientRegisterAvailability
Fluconazole 100 mg tabletOralGeneric nameFluconazoleUS FDAAvailable on request
Fluconazole 150 mg tabletOralGeneric nameFluconazoleUS FDAAvailable on request
Fluconazole 200 mg tabletOralGeneric nameFluconazoleUS FDAAvailable on request
Fluconazole 50 mg tabletOralGeneric nameFluconazoleUS FDAAvailable on request

Rheumatology

3 presentations

Rheumatology overview
MedicineActive ingredientRegisterAvailability
Naproxen 250 mg tabletOralGeneric nameNaproxenUS FDAAvailable on request
Naproxen 375 mg tabletOralGeneric nameNaproxenUS FDAAvailable on request
Naproxen 500 mg tabletOralGeneric nameNaproxenUS FDAAvailable on request

Neurology

2 presentations

Neurology overview
MedicineActive ingredientRegisterAvailability
Carbidopa and Levodopa 25 mg/100 mg extended-release tabletOralGeneric nameCarbidopa and LevodopaUS FDAAvailable on request
Carbidopa and Levodopa 50 mg/200 mg extended-release tabletOralGeneric nameCarbidopa and LevodopaUS FDAAvailable on request

Haematology

1 presentation

Haematology overview
MedicineActive ingredientRegisterAvailability
Clopidogrel 300 mg tabletOralGeneric nameClopidogrelUS FDAAvailable on request

Immunology and transplant

1 presentation

Immunology and transplant overview
MedicineActive ingredientRegisterAvailability
Tofacitinib 11 mg extended-release tabletOralGeneric nameTofacitinibUS FDAAvailable on request

Molecules made

Manufacturer facts come from public registers and are shown with their source. Listing does not mean the manufacturer endorses MedsAcross.

Source from Radha Pharmaceuticals

Send a request for any of these products. We confirm the licensed source, documents and lead time.